Drugs / INCA036873
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07195916 | Jan 2026 → Aug 2028 expected | cancer, hematopoietic and lymphoid cell neoplasm | Incyte Corporation | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INCA036873 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07195916 ↗ |
| Route | Intravenous | “Intravenously (IV)” NCT07195916 ↗ |